CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Tacrolimus (FK506) is safe and effective in patients with refractory extraintestinal manifestations of inflammatory bowel disease
DOI 10.1055/s-2006-950640
Bibliografische Angaben
Nachweis in CareLit
Autor:innenBT Tanczos, A Sturm, B Wiedenmann, A Dignaß, DC Baumgart
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Between five to twenty percent of inflammatory bowel disease patients develop extraintestinal disease manifestations (EIM), which do not always respond to conventional medical or topical therapy. Tacrolimus, a macrolide immunosuppressant inhibiting T-cell activation, is currently approved for the prophylaxis of organ rejection in patients receiving allogeneic liver or kidney transplants. We have recently publi…
Zitieren
Zitierempfehlung
BT Tanczos, A Sturm, B Wiedenmann, A Dignaß, DC Baumgart (2006) Tacrolimus (FK506) is safe and effective in patients with refractory extraintestinal manifestations of inflammatory bowel disease. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-2006-950640
Mit CareLit weiterarbeiten